phio pharmaceuticals announces upcoming presentation at asgct’s 2024 advancing gene + cell therapies for cancer conference
Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...